Ftse Mib
33.870,93
0,57%
DAX
18.996,63
0,89%
S&P 500
5.725,99
0,13%
NASDAQ
18.058,88
0,47%
Bitcoin
63.813,96
0,77%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ COMPASS Pathways PLC (CMPS) COMPASS Pathways PLC (CMPS) Notizie

CMPS

COMPASS Pathways (CMPS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CMPS
DataOraFonteTitoloSimboloCompagnia
24/09/202410:43Business WireCompass Pathways nimmt am Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit teilNASDAQ:CMPSCOMPASS Pathways PLC
24/09/202410:42Business WireCompass Pathways participera au Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry SummitNASDAQ:CMPSCOMPASS Pathways PLC
23/09/202413:00Business WireCompass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry SummitNASDAQ:CMPSCOMPASS Pathways PLC
05/08/202414:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPSCOMPASS Pathways PLC
01/08/202412:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPSCOMPASS Pathways PLC
01/08/202412:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPSCOMPASS Pathways PLC
01/08/202412:30GlobeNewswire Inc.Compass Pathways announces second quarter 2024 financial results and business highlightsNASDAQ:CMPSCOMPASS Pathways PLC
26/06/202412:30GlobeNewswire Inc.Compass Pathways appoints Lori Englebert as Chief Commercial OfficerNASDAQ:CMPSCOMPASS Pathways PLC
08/05/202412:45GlobeNewswire Inc.Compass Pathways Announces First Quarter 2024 Financial Results and Business HighlightsNASDAQ:CMPSCOMPASS Pathways PLC
08/05/202412:30GlobeNewswire Inc.Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorderNASDAQ:CMPSCOMPASS Pathways PLC
02/05/202412:30GlobeNewswire Inc.Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatmentNASDAQ:CMPSCOMPASS Pathways PLC
29/04/202412:30GlobeNewswire Inc.Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depressionNASDAQ:CMPSCOMPASS Pathways PLC
28/03/202413:00GlobeNewswire Inc.Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of DirectorsNASDAQ:CMPSCOMPASS Pathways PLC
05/03/202423:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CMPSCOMPASS Pathways PLC
29/02/202413:00GlobeNewswire Inc.Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights NASDAQ:CMPSCOMPASS Pathways PLC
29/02/202412:59Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CMPSCOMPASS Pathways PLC
14/02/202422:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CMPSCOMPASS Pathways PLC
16/01/202414:00GlobeNewswire Inc.Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approvedNASDAQ:CMPSCOMPASS Pathways PLC
05/01/202423:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CMPSCOMPASS Pathways PLC
05/01/202414:00GlobeNewswire Inc.Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreementNASDAQ:CMPSCOMPASS Pathways PLC
02/01/202423:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CMPSCOMPASS Pathways PLC
19/12/202322:05GlobeNewswire Inc.Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorderNASDAQ:CMPSCOMPASS Pathways PLC
13/12/202323:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CMPSCOMPASS Pathways PLC
07/12/202313:00GlobeNewswire Inc.Compass Pathways appoints Teri Loxam as Chief Financial OfficerNASDAQ:CMPSCOMPASS Pathways PLC
06/12/202322:00GlobeNewswire Inc.Study results of psilocybin treatment in bipolar II depression published in JAMA PsychiatryNASDAQ:CMPSCOMPASS Pathways PLC
15/11/202310:00GlobeNewswire Inc.Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research centerNASDAQ:CMPSCOMPASS Pathways PLC
02/11/202312:00GlobeNewswire Inc.COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:CMPSCOMPASS Pathways PLC
26/10/202314:00GlobeNewswire Inc.COMPASS Pathways announces CFO transitionNASDAQ:CMPSCOMPASS Pathways PLC
19/09/202315:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CMPSCOMPASS Pathways PLC
19/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMPSCOMPASS Pathways PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CMPS

La tua Cronologia

LSE
YB86
Citi Fun 33
USOTC
PIERF
Pierer Mobility Ag Ktm I... (PK)
TG
BA0AJT
Bank of America
TSXV
PTE
Pioneering Technology
CSE
VSBY.WT.B
VSBLTY Groupe Technologies
NASDAQ
AAZYRXX
Goldman Sachs Bank Usa A...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network